Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult Choice

Eteplirsen Approved for Duchenne Muscular Dystrophy: The FDA Faces a Difficult Choice Molecular Therapy 24, 1884 (November 2016). doi:10.1038/mt.2016.188 Author: Cy A Stein

http://feeds.nature.com/~r/mt/rss/current/~3/9y9GPeUneb4/mt.2016.188

Source: Molecular Therapy - December 4, 2016 Category: Genetics & Stem Cells Authors: Cy A Stein Source Type: research

More News: Genetics | Muscular Dystrophy | Reflex Sympathetic Dystrophy